NOTV.NASDAQInotiv, INC

Form 4: Inotiv Inc. Executive Granted Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Jeffrey Brennan Freeman, VP-Finance & Corp. Controller at Inotiv, Inc., received 20,000 stock options and 20,000 restricted stock units on August 10, 2024.

Summary

  • Jeffrey Brennan Freeman, VP-Finance & Corp. Controller at Inotiv, Inc., reported changes in beneficial ownership on August 14, 2024.
  • On August 10, 2024, Freeman was granted 20,000 shares of common stock as restricted stock units, vesting fully on June 18, 2026, contingent upon continued employment.
  • Additionally, Freeman received options to purchase 20,000 shares of common stock at an exercise price of $1.61.
  • These options vest over three years: 40% on June 18, 2025, 30% on June 18, 2026, and 30% on June 18, 2027, also subject to continued employment.
  • Following these transactions, Freeman directly owns 28,817 shares of Inotiv, Inc. common stock.
  • Freeman also directly owns 20,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options and restricted stock units is a standard practice, indicating confidence in the executive and aligning their interests with shareholders. There are no immediate negative implications.

Positives

  • The grant of restricted stock units and stock options to a key executive like the VP-Finance & Corp. Controller suggests an incentive alignment with the company's long-term performance.

Future Outlook

The vesting schedules for both the restricted stock units and stock options are contingent upon continued employment, indicating a focus on retaining key personnel.

Industry Context

Stock option and restricted stock grants are common practices in the biotech and pharmaceutical services industry to incentivize and retain key executives. These grants align executive compensation with company performance and shareholder value.

Comparison to Industry Standards

  • Companies like Charles River Laboratories and Envigo (now part of Inotiv) also use stock options and restricted stock units as part of their executive compensation packages.
  • The vesting schedules and grant sizes are generally comparable to industry standards for similar roles and company sizes.

Stakeholder Impact

  • Shareholders may view the grant of stock options and restricted stock units positively, as it aligns executive interests with long-term company performance.
  • Employees may see this as a positive sign of the company's commitment to its leadership team.

Key Dates

DateDescription
08/10/2024Date of transaction: Grant of restricted stock units and stock options.
08/14/2024Date of filing: Form 4 filing date.
06/18/202540% of stock options vest.
06/18/2026Restricted stock units vest in full; 30% of stock options vest.
06/18/202730% of stock options vest.
08/09/2034Expiration date of stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.